Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by SPCEO1 on Jun 19, 2023 5:46pm

FYI

https://qrius.com/what-is-the-connection-between-tesamorelin-and-adipose-tissue/
Comment by Trogarzon on Jun 19, 2023 6:28pm
Great stuff. They could fill a national library with all the papers and studies accumulated on Tessa... but no partner. Strong negociating position, Paul said.. when was that.. 2 years ago... 
Comment by scarlet1967 on Jun 19, 2023 7:33pm
It's is somehow frustrating that various retailers line up all including not clinically approved therapeutic benefits of the drug to get sales. Maybe the MLS can mention the ongoing studies of Tesamorelin but I doubt doctors would recommend the drug based on only ongoing clinical trials of Tesamorelin for various conditions.
Comment by Trogarzon on Jun 19, 2023 7:48pm
Do we know if they are working on a partnership at the moment in Nash or Onco.  Do we have an idea of the enrolment of the resarted Th1902 study.  When do we expect top line results.  What will be the news flow before Th1902 results and when can we exect those.  What's the strategy in regards to the Nasdaq ultimatum.  I mean these are all basic questions we don't ...more  
Comment by SPCEO1 on Jun 19, 2023 11:10pm
We cannot know about partnership deals until the company decides to reveal info about it. I think it is safe to conclude nothing is going on a NASH partnership but also safe to believe preliminary discussions could be happening on the cancer front. Enrollment in the restarted trial should start around quarter end. No announcement has been made about when to expect top line results on the restarted ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities